1: Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age.

[Hommers Leif,Scherf-Clavel Maike,Stempel Roberta,Roth Julian,Falter Matthias,Deckert Jürgen,Mattheisen Manuel,Unterecker Stefan,Gawlik Micha]
J Psychopharmacol,2021 Mar 28;2698811211003477. PMID: 33779379

2: Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval.

[Okayasu Hiroaki,Shinozaki Takahiro,Takano Yumiko,Sugawara Norio,Fujii Kumiko,Yasui-Furukori Norio,Ozeki Yuji,Shimoda Kazutaka]
Neuropsychiatr Dis Treat,2021 Jan 27;17:239-249. PMID: 33542628

3: {'sub': 'C', '#text': 'Effect of domperidone, ondansetron, olanzapine-containing antiemetic regimen on QT interval in patients with malignancy: a prospective, observational, single-group, assessor-blinded study.'}

[Kamath Ashwin,Rai K Maneesh,Shreyas R,Saxena P U Prakash,Banerjee Sourjya]
Sci Rep,2021 Jan 11;11(1):445. PMID: 33431995

4: Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany.

[Elsayed Mohamed,Abdel-Kahaar Emaad,Gahr Maximilian,Connemann Bernhard J,Denkinger Michael,Schönfeldt-Lecuona Carlos]
Eur J Clin Pharmacol,2021 May;77(5):767-775. PMID: 33230596

5: Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.

[Sun Lei,Yagoda Sergey,Xue Hongqi,Brown Randy,Nangia Narinder,McDonnell David,Rege Bhaskar,von Moltke Lisa,Darpo Borje]
Prog Neuropsychopharmacol Biol Psychiatry,2020 Jun 8;100:109881. PMID: 32004636

6: Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand.

[Waleekhachonloet Onanong,Limwattananon Chulaporn,Rattanachotphanit Thananan]
Ther Adv Drug Saf,2019 Jun 13;10:2042098619854886. PMID: 31223470

7: Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.

[Smith Robert C,Leucht Stefan,Davis John M]
Psychopharmacology (Berl),2019 Feb;236(2):545-559. PMID: 30506237

8: Antipsychotics for treatment of delirium in hospitalised non-ICU patients.

[Burry Lisa,Mehta Sangeeta,Perreault Marc M,Luxenberg Jay S,Siddiqi Najma,Hutton Brian,Fergusson Dean A,Bell Chaim,Rose Louise]
Cochrane Database Syst Rev,2018 Jun 18;6(6):CD005594. PMID: 29920656

9: Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders.

[Aronow Wilbert S,Shamliyan Tatyana A]
Ann Transl Med,2018 Apr;6(8):147. PMID: 29862236

10: QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.

[Spellmann Ilja,Reinhard Matthias A,Veverka Diana,Zill Peter,Obermeier Michael,Dehning Sandra,Schennach Rebecca,Müller Norbert,Möller Hans-Jürgen,Riedel Michael,Musil Richard]
Eur Arch Psychiatry Clin Neurosci,2018 Jun;268(4):383-390. PMID: 29429138

11: {'#text': 'Validation and Clinical Utility of the hERG IC50:C Ratio to Determine the Risk of Drug-Induced Torsades de Pointes: A Meta-Analysis.', 'sub': 'max'}

[Lehmann David F,Eggleston William D,Wang Dongliang]
Pharmacotherapy,2018 Mar;38(3):341-348. PMID: 29380488

12: Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.

[Khan Qasim,Ismail Mohammad,Haider Iqbal,Khan Fahadullah]
Int J Clin Pharm,2017 Dec;39(6):1256-1264. PMID: 28895028

13: BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.

[Strinic Dean,Belosic Halle Zeljka,Luetic Kresimir,Nedic Ana,Petrovic Igor,Sucic Mario,Zivanovic Posilovic Gordana,Balenovic Dijana,Strbe Sanja,Udovicic Mario,Drmic Domagoj,Stupnisek Mirjana,Lovric Bencic Martina,Seiwerth Sven,Sikiric Predrag]
Life Sci,2017 Oct 1;186:66-79. PMID: 28797793

14: Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia.

[Viscogliosi Giovanni,Chiriac Iulia Maria,Ettorre Evaristo]
J Am Med Dir Assoc,2017 Sep 1;18(9):799-802. PMID: 28739492

15: Influence of different second generation antipsychotics on the QTc interval: A pragmatic study.

[Olsen Roy E,Kroken Rune A,Bjørhovde Sigmund,Aanesen Kristina,Jørgensen Hugo A,Løberg Else-Marie,Johnsen Erik]
World J Psychiatry,2016 Dec 22;6(4):442-448. PMID: 28078208

16: Lurasidone: an antipsychotic with antidepressant effects in bipolar depression?

[Keks Nicholas A,Hope Judy,Castle David]
Australas Psychiatry,2016 Jun;24(3):289-91. PMID: 27036122

17: Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.

[Alda José A,Muñoz-Samons Daniel,Tor Jordina,Merchán-Naranjo Jessica,Tapia-Casellas Cecilia,Baeza Inmaculada,Calvo-Escalona Rosa,Castro-Fornieles Josefina,Martínez-Cantarero Carmen,Andrés-Nestares Patricia,Fernández-Avilés Francisco,Arango Celso]
J Child Adolesc Psychopharmacol,2016 Jun;26(5):449-57. PMID: 26779966

18: [The Safety of Using Long-acting Injections : From an Opposing Position-Is It Better to Administer Long-acting Injections?].

[Suzuki Yutaro]
Seishin Shinkeigaku Zasshi,2016;118(8):584-588. PMID: 30620476

19: Asenapine for bipolar disorder.

[Scheidemantel Thomas,Korobkova Irina,Rej Soham,Sajatovic Martha]
Neuropsychiatr Dis Treat,2015 Dec 4;11:3007-17. PMID: 26674884

20: The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

[Raschi Emanuel,Poluzzi Elisabetta,Salvo Francesco,Koci Ariola,Suling Marc,Antoniazzi Stefania,Perina Luisella,Hazell Lorna,Moretti Ugo,Sturkenboom Miriam,Garbe Edeltraut,Pariente Antoine,De Ponti Fabrizio]
Drug Saf,2016 Jan;39(1):59-68. PMID: 26446144

21: Intramuscular olanzapine for agitated patients: A systematic review and meta-analysis of randomized controlled trials.

[Kishi Taro,Matsunaga Shinji,Iwata Nakao]
J Psychiatr Res,2015 Sep;68:198-209. PMID: 26228420

22: Implications of atypical antipsychotic prescribing in the intensive care unit.

[Kram Bridgette L,Kram Shawn J,Brooks Kelli R]
J Crit Care,2015 Aug;30(4):814-8. PMID: 25887805

23: Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.

[Berling Ingrid,Isbister Geoffrey K]
Ann Emerg Med,2015 Aug;66(2):154-64. PMID: 25639523

24: Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.

[Kimura Goji,Kadoyama Kaori,Brown J B,Nakamura Tsutomu,Miki Ikuya,Nisiguchi Kohshi,Sakaeda Toshiyuki,Okuno Yasushi]
Int J Med Sci,2015 Jan 5;12(2):135-40. PMID: 25589889

25: Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.

[Jensen Karsten Gjessing,Juul Klaus,Fink-Jensen Anders,Correll Christoph U,Pagsberg Anne Katrine]
J Am Acad Child Adolesc Psychiatry,2015 Jan;54(1):25-36. PMID: 25524787

26: Olanzapine induced Q-Tc shortening.

[Shoja Shafti Saeed,Fallah Jahromi Parisa]
Ther Adv Psychopharmacol,2014 Dec;4(6):240-6. PMID: 25489475

27: Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis.

[Wang Jun,Liu Yan-song,Zhu Wen-xian,Zhang Fu-quan,Zhou Zhen-he]
Sci Rep,2014 Dec 9;4:7394. PMID: 25487560

28: Droperidol for the treatment of acute migraine headaches.

[Thomas Michael C,Musselman Megan E,Shewmaker Justin]
Ann Pharmacother,2015 Feb;49(2):233-40. PMID: 25416184

29: A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes.

[Shoja Shafti Saeed,Fallah Jahromi Parisa]
Cardiovasc Psychiatry Neurol,2014;2014:637016. PMID: 25276418

30: Management of psychosis and agitation in medical-surgical patients who have or are at risk for prolonged QT interval.

[Ries Rose,Sayadipour Amirali]
J Psychiatr Pract,2014 Sep;20(5):338-44. PMID: 25226194

31: Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

[Kishi Taro,Matsuda Yuki,Iwata Nakao]
PLoS One,2014 Feb 4;9(2):e88049. PMID: 24505373

32: Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia.

[Suzuki Yutaro,Sugai Takuro,Ono Shin,Sawamura Kazushi,Fukui Naoki,Watanabe Junzo,Tsuneyama Nobuto,Saito Mami,Someya Toshiyuki]
Psychiatry Clin Neurosci,2014 May;68(5):353-6. PMID: 24405493

33: Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care.

[Petersen A B,Andersen S E,Christensen M,Larsen H L]
Clin Toxicol (Phila),2014 Jan;52(1):39-43. PMID: 24313745

34: Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.

[Raschi Emanuel,Poluzzi Elisabetta,Godman Brian,Koci Ariola,Moretti Ugo,Kalaba Marija,Bennie Marion,Barbui Corrado,Wettermark Bjorn,Sturkenboom Miriam,De Ponti Fabrizio]
PLoS One,2013 Nov 20;8(11):e81208. PMID: 24278396

35: Quetiapine versus other atypical antipsychotics for schizophrenia.

[Asmal Laila,Flegar Srnka J,Wang Jikun,Rummel-Kluge Christine,Komossa Katja,Leucht Stefan]
Cochrane Database Syst Rev,2013 Nov 18;(11):CD006625. PMID: 24249315

36: Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.

[Leonard Charles E,Freeman Cristin P,Newcomb Craig W,Bilker Warren B,Kimmel Stephen E,Strom Brian L,Hennessy Sean]
J Clin Exp Cardiolog,2013;Suppl 10(6):1-9. PMID: 24027655

37: Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

[Leucht Stefan,Cipriani Andrea,Spineli Loukia,Mavridis Dimitris,Orey Deniz,Richter Franziska,Samara Myrto,Barbui Corrado,Engel Rolf R,Geddes John R,Kissling Werner,Stapf Marko Paul,Lässig Bettina,Salanti Georgia,Davis John M]
Lancet,2013 Sep 14;382(9896):951-62. PMID: 23810019

38: Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia.

[Suzuki Yutaro,Sugai Takuro,Fukui Naoki,Watanabe Junzo,Ono Shin,Tsuneyama Nobuto,Saito Mami,Someya Toshiyuki]
Hum Psychopharmacol,2013 Jan;28(1):94-6. PMID: 23161621

39: The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study.

[Kwon Jun Soo,Mittoux Aurélia,Hwang Jae Yeon,Ong Adeline,Cai Zhuo-Ji,Su Tung-Ping]
Int Clin Psychopharmacol,2012 Nov;27(6):326-35. PMID: 22850268

40: Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.

[Camm A John,Karayal Onur N,Meltzer Herbert,Kolluri Sheela,O'Gorman Cedric,Miceli Jeffrey,Tensfeldt Thomas,Kane John M]
CNS Drugs,2012 Apr 1;26(4):351-65. PMID: 22452529

41: Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.

[Watanabe Junzo,Suzuki Yutaro,Fukui Naoki,Ono Shin,Sugai Takuro,Tsuneyama Nobuto,Someya Toshiyuki]
J Clin Psychopharmacol,2012 Feb;32(1):18-22. PMID: 22198445

42: Lurasidone: a new treatment option for schizophrenia.

[Owen R T]
Drugs Today (Barc),2011 Nov;47(11):807-16. PMID: 22146224

43: [Electrocardiographic abnormalities in acute olanzapine poisonings].

[Ciszowski Krzysztof,Sein Anand Jacek]
Przegl Lek,2011;68(8):422-5. PMID: 22010429

44: Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia.

[Suzuki Yutaro,Ono Shin,Sugai Takuro,Fukui Naoki,Watanabe Junzo,Tsuneyama Nobuto,Sawamura Kazushi,Someya Toshiyuki]
Hum Psychopharmacol,2011 Aug;26(6):440-3. PMID: 21823168

45: Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.

[Meyer-Massetti Carla,Vaerini Simone,Rätz Bravo Alexandra E,Meier Christoph R,Guglielmo B Joseph]
Int J Clin Pharm,2011 Oct;33(5):806-14. PMID: 21809143

46: Complete atrioventricular block-induced Torsade de pointes, manifested by epilepsy.

[Jeon Jun Han,Her Sung Ho,Chin Jung Yeon,Park Ki Hoon,Yoon Hee Jeong,Lee Jong Min,Jin Seung Won]
Korean J Intern Med,2011 Mar;26(1):99-102. PMID: 21437170

47: Aripiprazole as a viable alternative for treating delusions of parasitosis.

[Ladizinski Barry,Busse Kristine L,Bhutani Tina,Koo John Y M]
J Drugs Dermatol,2010 Dec;9(12):1531-2. PMID: 21120263

48: Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).

[Strom Brian L,Eng Sybil M,Faich Gerald,Reynolds Robert F,D'Agostino Ralph B,Ruskin Jeremy,Kane John M]
Am J Psychiatry,2011 Feb;168(2):193-201. PMID: 21041245

49: QT alterations in psychopharmacology: proven candidates and suspects.

[Alvarez Paulino Antonio,Pahissa Jaime]
Curr Drug Saf,2010 Jan;5(1):97-104. PMID: 20210726

50: Quetiapine versus other atypical antipsychotics for schizophrenia.

[Komossa Katja,Rummel-Kluge Christine,Schmid Franziska,Hunger Heike,Schwarz Sandra,Srisurapanont Manit,Kissling Werner,Leucht Stefan]
Cochrane Database Syst Rev,2010 Jan 20;(1):CD006625. PMID: 20091600

51: QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.

[Ozeki Yuji,Fujii Kumiko,Kurimoto Naoki,Yamada Naoto,Okawa Masako,Aoki Takesuke,Takahashi Jun,Ishida Nobuya,Horie Minoru,Kunugi Hiroshi]
Prog Neuropsychopharmacol Biol Psychiatry,2010 Mar 17;34(2):401-5. PMID: 20079791

52: Arsenic trioxide and olanzapine co-administration: case analysis.

[Kaufman Kenneth R,Chhabra Saurabh,Levitt Michael,Sood Rahul]
J Oncol Pharm Pract,2011 Sep;17(3):260-4. PMID: 20015926

53: [Medication associated long QT syndrome].

[Bruggisser M,Rätz Bravo A,Bodmer M]
Praxis (Bern 1994),2009 Dec 2;98(24):1409-15; quiz 1415. PMID: 19953465

54: Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder.

[Bishara Delia,Taylor David]
Neuropsychiatr Dis Treat,2009;5:483-90. PMID: 19851515

55: Aripiprazole versus other atypical antipsychotics for schizophrenia.

[Komossa Katja,Rummel-Kluge Christine,Schmid Franziska,Hunger Heike,Schwarz Sandra,El-Sayeh Hany George G,Kissling Werner,Leucht Stefan]
Cochrane Database Syst Rev,2009 Oct 7;(4):CD006569. PMID: 19821375

56: Sertindole versus other atypical antipsychotics for schizophrenia.

[Komossa Katja,Rummel-Kluge Christine,Hunger Heike,Schwarz Sandra,Schmidt Franziska,Lewis Ruth,Kissling Werner,Leucht Stefan]
Cochrane Database Syst Rev,2009 Apr 15;(2):CD006752. PMID: 19370652

57: Pediatric ziprasidone overdose.

[Fasano Charles J,O'Malley Gerald F,Lares Claudia,Rowden Adam K]
Pediatr Emerg Care,2009 Apr;25(4):258-9. PMID: 19369840

58: QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa.

[Ritchie Blair,Norris Mark L]
J Can Acad Child Adolesc Psychiatry,2009 Feb;18(1):60-3. PMID: 19270852

59: Treatment of bipolar disorder: the evolving role of atypical antipsychotics.

[Perlis Roy H]
Am J Manag Care,2007 Nov;13(7 Suppl):S178-88. PMID: 18041879

60: Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.

Prescrire Int,2007 Apr;16(88):59-62. PMID: 17458045

61: Sertindole: efficacy and safety in schizophrenia.

[Lindström Eva,Levander Sten]
Expert Opin Pharmacother,2006 Sep;7(13):1825-34. PMID: 16925508

62: [Differences between men and women in side effects of second-generation antipsychotics].

[Aichhorn W,Whitworth A B,Weiss E M,Hinterhuber H,Marksteiner J]
Nervenarzt,2007 Jan;78(1):45-52. PMID: 16874502

63: Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis.

[Crumb William J,Ekins Sean,Sarazan R Dustan,Wikel James H,Wrighton Steven A,Carlson Christopher,Beasley Charles M]
Pharm Res,2006 Jun;23(6):1133-43. PMID: 16715368

64: Aripiprazole: new drug. Just another neuroleptic.

Prescrire Int,2005 Oct;14(79):163-7. PMID: 16285069

65: Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.

Prescrire Int,2005 Aug;14(78):140-2. PMID: 16106596

66: Antipsychotic drugs and QT prolongation.

[Stöllberger Claudia,Huber Johannes O,Finsterer Josef]
Int Clin Psychopharmacol,2005 Sep;20(5):243-51. PMID: 16096514

67: Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine.

[Letsas Konstantinos P,Sideris Antonios,Kounas Stavros P,Efremidis Michalis,Korantzopoulos Panagiotis,Kardaras Fotios]
Int J Cardiol,2006 May 10;109(2):273-4. PMID: 15935493

68: QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy.

[Sala Michela,Vicentini Alessandro,Brambilla Paolo,Montomoli Cristina,Jogia Jigar Rs,Caverzasi Eduardo,Bonzano Alberto,Piccinelli Marco,Barale Francesco,De Ferrari Gaetano M]
Ann Gen Psychiatry,2005 Jan 25;4(1):1. PMID: 15845138

69: Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

[Titier Karine,Girodet Pierre-Olivier,Verdoux Hélène,Molimard Mathieu,Bégaud Bernard,Haverkamp Wilhelm,Lader Malcolm,Moore Nicholas]
Drug Saf,2005;28(1):35-51. PMID: 15649104

70: [QT prolongation and second-generation antipsychotics: overdose and therapeutic dosage].

[Trojak Benoît,Pinoit Jean-Michel,Disson-Dautriche Anne,Bonin Bernard,Giusselmann André]
Therapie,Sep-Oct 2004;59(5):558-61. PMID: 15648310

71: Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice.

[Titier Karine,Canal Mireille,Déridet Evelyne,Abouelfath Abdelilah,Gromb Sophie,Molimard Mathieu,Moore Nicholas]
Toxicol Appl Pharmacol,2004 Aug 15;199(1):52-60. PMID: 15289090

72: Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome.

[Su Kuan-Pin,Lane Hsien-Yuan,Chuang Chiao-Lin,Chen Kun-Po,Shen Winston W]
Schizophr Res,2004 Feb 1;66(2-3):191-2. PMID: 15061254

73: Using antipsychotic agents in older patients.

[Alexopoulos George S,Streim Joel,Carpenter Daniel,Docherty John P,Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients]
J Clin Psychiatry,2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. PMID: 14994733

74: A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.

[Harrigan Edmund P,Miceli Jeffrey J,Anziano Richard,Watsky Eric,Reeves Karen R,Cutler Neal R,Sramek John,Shiovitz Thomas,Middle Michelle]
J Clin Psychopharmacol,2004 Feb;24(1):62-9. PMID: 14709949

75: Antipsychotic drugs and QT interval prolongation.

[Zareba Wojciech,Lin David A]
Psychiatr Q,Fall 2003;74(3):291-306. PMID: 12918603

76: QTc prolongation: chlorpromazine and high-dosage olanzapine.

[Gurovich Irina,Vempaty Anitha,Lippmann Steven]
Can J Psychiatry,2003 Jun;48(5):348. PMID: 12866343

77: Ziprasidone in the management of schizophrenia : the QT interval issue in context.

[Taylor David]
CNS Drugs,2003;17(6):423-30. PMID: 12697001

78: QTc prolongation and high-dose olanzapine.

[Dineen Sean,Withrow Kirk,Voronovitch Liouda,Munshi Firoz,Nawbary Mohammad Wally,Lippmann Steven]
Psychosomatics,Mar-Apr 2003;44(2):174-5. PMID: 12618539

79: Investigation of the potential of clozapine to cause torsade de pointes.

[Warner Barbara,Hoffmann Peter]
Adverse Drug React Toxicol Rev,2002;21(4):189-203. PMID: 12503253

80: A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.

[Kongsamut Sathapana,Kang Jiesheng,Chen Xiao-Liang,Roehr Joachim,Rampe David]
Eur J Pharmacol,2002 Aug 16;450(1):37-41. PMID: 12176106

81: Ziprasidone: profile on safety.

[Goodnick P J]
Expert Opin Pharmacother,2001 Oct;2(10):1655-62. PMID: 11825308

82: Tolerability profile of atypical antipsychotics in children and adolescents.

[Stigler K A,Potenza M N,McDougle C J]
Paediatr Drugs,2001;3(12):927-42. PMID: 11772153

83: Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.

[Glassman A H,Bigger J T]
Am J Psychiatry,2001 Nov;158(11):1774-82. PMID: 11691681

84: Olanzapine: new preparation. Keep an eye on this neuroleptic.

Prescrire Int,1999 Oct;8(43):135-8. PMID: 11503836

85: Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

[Czekalla J,Beasley C M,Dellva M A,Berg P H,Grundy S]
J Clin Psychiatry,2001 Mar;62(3):191-8. PMID: 11305706

86: Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics.

[Czekalla J,Kollack-Walker S,Beasley C M]
J Clin Psychiatry,2001;62 Suppl 2:35-40. PMID: 11232751

87: Olanzapine. Keep an eye on this neuroleptic.

Can Fam Physician,2000 Feb;46:322-6, 330-6. PMID: 10690489

88: The metabolism of atypical antipsychotic drugs: an update.

[Shen W W]
Ann Clin Psychiatry,1999 Sep;11(3):145-58. PMID: 10482125

89: The use of atypical antipsychotics in the management of schizophrenia.

[Campbell M,Young P I,Bateman D N,Smith J M,Thomas S H]
Br J Clin Pharmacol,1999 Jan;47(1):13-22. PMID: 10073734

90: Prolongation of QT interval in isolated feline hearts by antipsychotic drugs.

[Drici M D,Wang W X,Liu X K,Woosley R L,Flockhart D A]
J Clin Psychopharmacol,1998 Dec;18(6):477-81. PMID: 9864081